In this article, we discuss the 5 new stock picks of billionaire Ray Dalio. If you want to read our detailed analysis of these stocks, go directly to the 10 New Stock Picks of Billionaire Ray Dalio.
5. Moderna, Inc. (NASDAQ:MRNA)
Number of Hedge Fund Holders: 37
Moderna, Inc. (NASDAQ:MRNA) is a biotech firm that develops vaccines for people with infectious diseases. Regulatory filings show that Bridgewater Associates owned 8,309 shares in the company at the end of the third quarter of 2021 worth over $3.1 million, representing a very small portion of the portfolio.
On November 8, investment advisory Wolfe Research initiated coverage of Moderna, Inc. (NASDAQ:MRNA) stock with an Outperform rating and a price target of $304. Analyst Andrew Galler issued the ratings update.
At the end of the second quarter of 2021, 37 hedge funds in the database of Insider Monkey held stakes worth $5.7 billion in Moderna, Inc. (NASDAQ:MRNA), down from 39 in the preceding quarter worth $1.6 billion.
In its Q2 2021 investor letter, Baillie Gifford, an asset management firm, highlighted a few stocks and Moderna, Inc. (NASDAQ:MRNA) was one of them. Here is what the fund said:
“Among the top contributors to Fund performance in the second quarter was Moderna. Moderna has just reported its first profitable quarter in the company’s history – net income for the most recent quarter was $1.2 billion. It reported revenue of $1.9 billion, an impressive increase compared to $8 million a year ago, driven by the sales of its Covid-19 vaccine. Moderna is expecting to deliver up to 1 billion vaccine doses in 2021 and is in discussions to increase global supply to governments around the world. Our long-term focus remains on the transformational potential of Moderna’s technology and its ability to address different diseases.”
4. Coursera, Inc. (NYSE:COUR)
Number of Hedge Fund Holders: 11
Coursera, Inc. (NYSE:COUR) owns and runs an online education platform. The company had passed the $100 million in quarterly revenue landmark in the second quarter this year and the earnings for the third quarter have also managed to top analyst expectations.
According to the latest data, Bridgewater Associates owned 218,862 shares in Coursera, Inc. (NYSE:COUR) at the end of September 2021 worth $6.9 million, representing 0.03% of the portfolio of the fund.
At the end of the second quarter of 2021, 11 hedge funds in the database of Insider Monkey held stakes worth $52 million in Coursera, Inc. (NYSE:COUR), down from 25 in the previous quarter worth $119 million.
3. OptimizeRx Corporation (NASDAQ:OPRX)
Number of Hedge Fund Holders: 13
OptimizeRx Corporation (NASDAQ:OPRX) is a digital solutions firm that provides services to the health industry. Securities filings show that Bridgewater Associates owned 28,550 shares in the company at the end of the third quarter of 2021 worth $2.4 million, representing 0.01% of the portfolio.
Roth Capital analyst Richard Baldry has a Buy rating on OptimizeRx Corporation (NASDAQ:OPRX) stock with a price target of $112. In an investor note penned on November 10, the analyst highlighted a “growing pipeline of opportunities” for the firm in the months ahead.
At the end of the second quarter of 2021, 13 hedge funds in the database of Insider Monkey held stakes worth $66 million in OptimizeRx Corporation (NASDAQ:OPRX), up from 11 in the previous quarter worth $48 million.
In its Q3 2021 investor letter, Wasatch Advisors, an asset management firm, highlighted a few stocks and OptimizeRx Corporation (NASDAQ:OPRX) was one of them. Here is what the fund said:
“Fund holding OptimizeRX Corp. (OPRX) was up during the quarter too. The company provides digital-marketing services for pharmaceutical and other health-care-related businesses. In 2019, the company’s stock price fell based on a decline in revenue, which was partly due to the delayed digital-advertising spending of two large pharmaceutical-business clients that merged. Back then, we continued to like OptimizeRX because we were impressed with the company’s cost-effective program to engage patients, enhance their health-care experiences and improve outcomes. Our willingness to stay the course has now been rewarded with a large gain in the stock based on the revenue and earnings growth we had correctly anticipated in 2019. OptimizeRX is currently under review due to our concern that the valuation may have gotten a bit ahead of fundamentals.”
2. Pembina Pipeline Corporation (NYSE:PBA)
Number of Hedge Fund Holders: 15
Pembina Pipeline Corporation (NYSE:PBA) provides transportation services primarily to the energy industry. The company has an impressive dividend history and recently declared a monthly dividend of C$0.21 per share, in line with previous. The forward yield was 6.2%.
Bridgewater Associates owned 101,164 shares in Pembina Pipeline Corporation (NYSE:PBA) at the end of September 2021 worth $3.2 million, representing 0.01% of the portfolio.
At the end of the second quarter of 2021, 15 hedge funds in the database of Insider Monkey held stakes worth $116 million in Pembina Pipeline Corporation (NYSE:PBA), the same as in the preceding quarter worth $74 million.
1. Western Alliance Bancorporation (NYSE:WAL)
Number of Hedge Fund Holders: 28
Western Alliance Bancorporation (NYSE:WAL) is a bank holding based in Arizona. Bridgewater Associates owned 38,163 shares in the company at the end of September 2021 worth $4.1 million, representing 0.02% of the portfolio of the fund.
Wells Fargo analyst Timur Braziler recently raised the price target on Western Alliance Bancorporation (NYSE:WAL) stock to $150 from $135 and kept an Overweight rating, noting the firm was “hitting on all cylinders” and the balance sheet growth was as good as any other bank.
At the end of the second quarter of 2021, 28 hedge funds in the database of Insider Monkey held stakes worth $188 million in Western Alliance Bancorporation (NYSE:WAL), up from 23 in the preceding quarter worth $141 million.
You can also take a peek at 10 Best Healthcare Dividend Stocks to Buy Now and 10 Dividend Stocks with Over 20 Years of Dividend Increases.
